 |
|
Dermatologic Radiotherapy and Thyroid CancerDose Measurements and Risk Quantification
Herbert Goldschmidt, MD;
Robert O. Gorson, MS;
Margit Lassen, PhD
Arch Dermatol. 1983;119(5):383-390.
Abstract
• Thyroid doses for various dermatologic radiation techniques were measured with thermoluminescent dosimeters and ionization rate meters in an Alderson-Rando anthropomorphic phantom. The effects of changes in radiation quality and of the use or nonuse of treatment cones and thyroid shields were evaluated in detail. The results indicate that the potential risk of radiogenic thyroid cancer is very small when proper radiation protection measures are used. The probability of radiogenic thyroid cancer developing and the potential mortality risk were assessed quantitatively for each measurement. The quantification of radiation risks allows comparisons with risks of other therapeutic modalities and the common hazards of daily life.
(Arch Dermatol 1983;119:383-390)
Author Affiliations
From the Department of Dermatology, University of Pennsylvania Medical School (Dr Goldschmidt), and the Department of Radiology, Division of Medical Physics, Jefferson Medical College of Thomas Jefferson University (Mr Gorson and Dr Lassen), Philadelphia.
Footnotes
Accepted for publication Aug 20, 1982.
Reprints not available.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Dermatologic Radiation and Cancer
Gladstein
Arch Dermatol 1990;126:120-121.
ABSTRACT
Cancer Risk Associated With Therapeutic Irradiation of Skin
Burns
Arch Dermatol 1989;125:979-981.
ABSTRACT
Dermatologic Radiotherapy: The Risk-Benefit Ratio
Goldschmidt
Arch Dermatol 1986;122:1385-1388.
ABSTRACT
|
